MOTS-c 40mg

MOTS-c Peptide

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a naturally occurring, 16-amino acid peptide encoded by the mitochondrial genome rather than the nuclear genome. It belongs to a unique class of signaling molecules known as mitochondrial-derived peptides (MDPs). Identified in 2015, MOTS-c acts as a metabolic hormone that translocates to the nucleus in response to metabolic stress, where it regulates nuclear gene expression to promote adaptive physiological changes.

Researchers have identified MOTS-c as a primary mediator of the “mitochondrial-to-nuclear” communication pathway. Unlike traditional hormones that are secreted by glands, MOTS-c is produced within the mitochondria—the cell’s energy powerhouse—and functions to harmonize systemic metabolism with cellular energy status. Its primary mechanism involves the activation of the AMP-activated protein kinase (AMPK) pathway and the glucose transporter GLUT4, which are critical regulators of energy balance and glucose uptake.

Overview

MOTS-c is often referred to as an “exercise mimetic” because its physiological effects closely resemble those induced by physical activity. While most genetic information is housed in the cell nucleus, the discovery of MOTS-c highlighted the mitochondria’s role as an active endocrine organ capable of influencing systemic insulin sensitivity and longevity.

Preliminary studies suggest that MOTS-c levels decline with age, a factor that may contribute to the development of age-related metabolic decline. By stimulating the AMPK pathway, MOTS-c enhances fatty acid oxidation and inhibits de novo lipogenesis (the creation of new fat). In research settings, it is being investigated for its potential to restore metabolic flexibility, improve physical performance, and counter the effects of a high-fat diet.

Chemical Makeup

• Molecular Formula: C101H152N28O22S2
• Molecular Weight: 2174.62 g/mol
• Amino Acid Sequence: Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Met-Cys-Ser-Ser-Asp-Ser

---

Research Studies and Clinical Trials

MOTS-c and Metabolic Homeostasis

In foundational laboratory studies, MOTS-c has demonstrated a robust ability to prevent insulin resistance. Research involving murine models on high-fat diets showed that exogenous MOTS-c administration significantly reduced weight gain and improved glucose tolerance. Scientists observed that the peptide targets skeletal muscle to increase glucose uptake, effectively bypassing certain defects in the insulin signaling pathway by utilizing the AMPK-dependent mechanism.

Physical Performance and Aging

Research published in journals such as Nature Communications has explored the link between MOTS-c and physical capacity. In these studies, older mice treated with MOTS-c exhibited a significant increase in treadmill running performance and grip strength compared to age-matched controls. The data suggested that the peptide helps maintain “metabolic fitness” by optimizing the way cells utilize fuel during periods of high demand, potentially delaying the onset of age-related frailty.

Mitochondrial-Nuclear Signaling and Stress Response

A unique aspect of MOTS-c research involves its translocation to the nucleus during metabolic stress (such as folate deprivation or exercise). Once in the nucleus, MOTS-c interacts with transcription factors like ARE (Antioxidant Response Element) to regulate genes involved in antioxidant defenses and glucose metabolism. This suggests that MOTS-c acts as a protective “sensor” that helps cells adapt to nutritional and environmental stressors.

Cardiovascular and Bone Health

Emerging research is investigating the pleiotropic effects of MOTS-c beyond glucose metabolism. Some studies indicate that the peptide may promote the differentiation of osteoblasts (bone-forming cells) while inhibiting osteoclasts, suggesting a potential role in maintaining bone density. Additionally, early-stage cardiovascular research is looking into how MOTS-c influences endothelial function and reduces inflammation within the vascular system.

---

Disclaimer: MOTS-c is an endogenous peptide currently being studied for its therapeutic potential. This description is for informational purposes based on current scientific literature and does not constitute medical advice. MOTS-c is available for research and laboratory purposes only.